SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001936249-24-000001
Filing Date
2024-02-06
Accepted
2024-02-06 20:55:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5037
  Complete submission text file 0001936249-24-000001.txt   6826
Mailing Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124
Business Address 55TH-56TH FLOOR, NEW BUND CENTER 555 WEST HAIYANG ROAD, PUDONG DISTRICT SHANGHAI F4 200124 862160578000
I-Mab (Subject) CIK: 0001778016 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91674 | Film No.: 24601873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8 CONNAUGHT PL 1308, TWO EXCHANGE SQUARE CENTRAL K3 00-000000
Business Address 8 CONNAUGHT PL 1308, TWO EXCHANGE SQUARE CENTRAL K3 00-000000 37920919
Infini Capital Management Ltd (Filed by) CIK: 0001936249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SCHEDULE 13G